Usage: ALKINDI SPRINKLE is indicated for use as replacement therapy in pediatric patients diagnosed with adrenocortical insufficiency.
carglumic acid
(Carglumic Acid)
Eton Pharmaceuticals, Inc.
Usage: Carglumic acid tablets are indicated for adults and pediatric patients as adjunctive therapy for acute hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency and for maintenance treatment of chronic hyperammonemia due to the same condition.
galzin
(Zinc Acetate)
Eton Pharmaceuticals, Inc.
Usage: Zinc acetate is indicated for the maintenance treatment of patients with Wilson’s disease who have previously received initial therapy with a chelating agent.
khindivi
(Hydrocortisone)
Eton Pharmaceuticals, Inc.
Usage: KHINDIVI is indicated for replacement therapy in pediatric patients aged 5 and older with adrenocortical insufficiency. It is not approved for increased dosing during stress or acute events; alternative hydrocortisone-containing products should be used for those situations.